Vol 2005, No 62 (2005)

Table of Contents

Research & Development

GlaxoSmithKline and Vitae Sign Hypertension Collaboration Abstract pdf
Business Review Editor

Features

Alkermes, Cephalon and Vivitrex#174;: Pioneering the Alcohol Dependence Market Abstract pdf
Business Review Editor
Pfizer and Vicuron: A Taste of Things to Come? Abstract pdf
Business Review Editor
The Supreme Court Changes Biotech Deal Flow Abstract pdf
Business Review Editor
Therapy Focus: Acute Myeloid Leukaemia Abstract pdf
Business Review Editor

Licensing

Arrow and Novartis Agree on RSV Abstract pdf
Business Review Editor

General

Merck and Metabasis Target Metabolic Diseases Abstract
Business Review Editor

Company Profile

Arrow Therapeutics Ltd. Abstract pdf
Business Review Editor

Distribution & Marketing

Procter & Gamble to Co-Promote Novartis’ Enablex® Abstract pdf
Business Review Editor

Business Commentaries

Biotechnology Means Hope html
Fintan Walton

Deal Trackers

Byetta (exenatide) Abstract pdf
Business Review Editor

Mergers & Acquisitions

Salix to Acquire InKine in Gastrointestinal Merger Abstract pdf
Business Review Editor
UK Acquisitions Hit the Headlines Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.